These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21038321)

  • 1. Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery.
    Hu J; Eriksson PO; Kern G
    Magn Reson Chem; 2010 Dec; 48(12):909-11. PubMed ID: 21038321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient use of the WATERGATE W5 sequence for observing a ligand binding with a protein receptor.
    Furihata K; Shimotakahara S; Tashiro M
    Magn Reson Chem; 2008 Sep; 46(9):799-802. PubMed ID: 18537106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of NMR screening techniques for observing ligand binding with a protein receptor.
    Shimotakahara S; Furihata K; Tashiro M
    Magn Reson Chem; 2005 Jan; 43(1):69-72. PubMed ID: 15476289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery.
    Raingeval C; Cala O; Brion B; Le Borgne M; Hubbard RE; Krimm I
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1218-1225. PubMed ID: 31286785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time efficient detection of protein-ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment.
    Gossert AD; Henry C; Blommers MJ; Jahnke W; Fernández C
    J Biomol NMR; 2009 Apr; 43(4):211-7. PubMed ID: 19205897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BEAR, a novel virtual screening methodology for drug discovery.
    Degliesposti G; Portioli C; Parenti MD; Rastelli G
    J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomolecular ligands screening using radiation damping difference WaterLOGSY spectroscopy.
    Sun P; Jiang X; Jiang B; Zhang X; Liu M
    J Biomol NMR; 2013 Jul; 56(3):285-90. PubMed ID: 23740293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-Small Molecule Interactions by WaterLOGSY.
    Huang R; Leung IKH
    Methods Enzymol; 2019; 615():477-500. PubMed ID: 30638539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.
    Di Micco S; Vitale R; Pellecchia M; Rega MF; Riva R; Basso A; Bifulco G
    J Med Chem; 2009 Dec; 52(23):7856-67. PubMed ID: 19852471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative time- and frequency-domain analysis of the two-pulse COSY revamped by asymmetric Z-gradient echo detection NMR experiment: Theoretical and experimental aspects, time-zero data truncation artifacts, and radiation damping.
    Kirsch S; Hull WE
    J Chem Phys; 2008 Jul; 129(4):044505. PubMed ID: 18681658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NMR screening of potential inhibitors of Citrobacter freundii methionine].
    Batuev EA; Lizunov AIu; Morozova EA; Klochkov VV; Anufrieva NV; Demidkina TV; Pol'shakov VI
    Mol Biol (Mosk); 2014; 48(6):1019-29. PubMed ID: 25845243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast and Efficient Fragment-Based Lead Generation by Fully Automated Processing and Analysis of Ligand-Observed NMR Binding Data.
    Peng C; Frommlet A; Perez M; Cobas C; Blechschmidt A; Dominguez S; Lingel A
    J Med Chem; 2016 Apr; 59(7):3303-10. PubMed ID: 26964888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based nuclear magnetic resonance screening techniques.
    Viegas A; Macedo AL; Cabrita EJ
    Methods Mol Biol; 2009; 572():81-100. PubMed ID: 20694687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NMR screening in fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.